Q32 Bio on Monday sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics Inc. (NASDAQ: AKBA). ADX-097, the lead product candidate from Q32 Bio’s tissue-targeted complement inhibitor ...
Nuvation Bio, Inc. (NYSE:NUVB) is one of the best small-cap biotech stocks to buy according to hedge funds. The stock’s price more than doubled from a year ago, up 156.7%, while it registered a 40.79% ...
Driven by a super boom in the memory semiconductor sector, the KOSPI index has been hitting record highs day after day.
Small-cap investors are convinced the stock-market tide has turned in their favor Small-cap stocks are off to a strong start in 2026. But investors shouldn't get carried away just yet. Small-cap's ...
Small-cap stocks have lagged behind their larger counterparts for more than 20 years, leaving beleaguered small-cap investors to wonder if smaller stocks will finally start to outperform the ...
Hosted on MSN
Bio stocks consolidate, anticipate second rise
Despite strong gains during last month’s market correction, bio stocks entered a consolidation phase this month. According to the Korea Exchange on the 15th, the ‘KRX 300 Healthcare’ index fell by 2.4 ...
ORLANDO, FL / ACCESS Newswire / April 10, 2026 / RedChip Companies will air interviews with BIO-key International, Inc. (Nasdaq:BKYI), 20/20 Biolabs, Inc. (Nasdaq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results